Rilpivirine

Janessa M. Smith, PharmD, BCPS, Paul Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID

INDICATIONS

FDA

Rilpivirine in combination with other ARVs is indicated for the treatment of HIV-1 infection in ART-naïve patients with HIV-1 RNA < 100,000 copies/mL.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: April 8, 2019